Sun Mingyang, Xu Shiqiang, Mei Yu, Li Jingyu, Gu Yan, Zhang Wenting, Wang Jihua
Crops Research Institute, Guangdong Academy of Agricultural Sciences, Guangzhou 510640, China.
Guangdong Provincial Key Laboratory of Crop Genetic Improvement, Guangdong Academy of Agricultural Sciences, Guangzhou 510640, China.
Int J Mol Sci. 2022 Sep 9;23(18):10477. doi: 10.3390/ijms231810477.
Medicinal plant microRNAs (miRNAs) are an endogenous class of small RNA central to the posttranscriptional regulation of gene expression. Biosynthetic research has shown that the mature miRNAs in medicinal plants can be produced from either the standard messenger RNA splicing mechanism or the pre-ribosomal RNA splicing process. The medicinal plant miRNA function is separated into two levels: (1) the cross-kingdom level, which is the regulation of disease-related genes in animal cells by oral intake, and (2) the intra-kingdom level, which is the participation of metabolism, development, and stress adaptation in homologous or heterologous plants. Increasing research continues to enrich the biosynthesis and function of medicinal plant miRNAs. In this review, peer-reviewed papers on medicinal plant miRNAs published on the Web of Science were discussed, covering a total of 78 species. The feasibility of the emerging role of medicinal plant miRNAs in regulating animal gene function was critically evaluated. Staged progress in intra-kingdom miRNA research has only been found in a few medicinal plants, which may be mainly inhibited by their long growth cycle, high demand for growth environment, immature genetic transformation, and difficult RNA extraction. The present review clarifies the research significance, opportunities, and challenges of medicinal plant miRNAs in drug development and agricultural production. The discussion of the latest results furthers the understanding of medicinal plant miRNAs and helps the rational design of the corresponding miRNA/target genes functional modules.
药用植物微小RNA(miRNA)是一类内源性小RNA,在基因表达的转录后调控中起核心作用。生物合成研究表明,药用植物中的成熟miRNA可以通过标准信使RNA剪接机制或前核糖体RNA剪接过程产生。药用植物miRNA的功能分为两个层面:(1)跨界层面,即通过口服摄入对动物细胞中疾病相关基因进行调控;(2)界内层面,即参与同源或异源植物的代谢、发育和胁迫适应。越来越多的研究不断丰富着药用植物miRNA的生物合成和功能。在本综述中,讨论了科学网上发表的关于药用植物miRNA的同行评审论文,共涵盖78个物种。对药用植物miRNA在调节动物基因功能方面新出现作用的可行性进行了批判性评估。界内miRNA研究的阶段性进展仅在少数药用植物中发现,这可能主要受到其生长周期长、对生长环境要求高、遗传转化不成熟以及RNA提取困难的抑制。本综述阐明了药用植物miRNA在药物开发和农业生产中的研究意义、机遇和挑战。对最新结果的讨论加深了对药用植物miRNA的理解,并有助于合理设计相应的miRNA/靶基因功能模块。